REQUEST A DEMO
Total
USD $0.00
Search more companies

29 Fevralya OOO (29 Февраля ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: 29 Fevralya OOO Profile Updated: March 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

29 Fevralya OOO (29 Февраля ООО) is an enterprise in Russia, with the main office in Saint Petersburg. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on March 25, 2019. There was a net sales revenue increase of 3.48% reported in 29 Fevralya OOO (29 Февраля ООО)’s latest financial highlights for 2024. There was a total growth of 35.6% in 29 Fevralya OOO (29 Февраля ООО)’s total assets over the same period. In, 2024, the company’s net profit margin increased by 4.66%.

Headquarters
Zheleznodorozhnyi, 40, D, 5-N
Saint Petersburg; Saint Petersburg; Postal Code: 192148

Contact Details: Purchase the 29 Fevralya OOO (29 Февраля ООО) report to view the information.

Basic Information
Financial Auditors:
Purchase the 29 Fevralya OOO (29 Февраля ООО) report to view the information.
Incorporation Date:
March 25, 2019
Company Performance
Financial values in the chart are available after 29 Fevralya OOO (29 Февраля ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
3.48%
Total operating revenue
3.48%
Operating profit (EBIT)
0.15%
Net Profit (Loss) for the Period
13.12%
Total Assets
35.6%
Total Equity
69.57%
Operating Profit Margin (ROS)
-1.99%
Net Profit Margin
4.66%
Return on Equity (ROE)
-20.48%
Debt/Equity
-5.67%
Quick Ratio
22.16%
Cash Ratio
0.7%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?